Annovis Bio Inc (ANVS)

[McMagyar]

annovis to present at Bio-CEO conference: here is link to register for presentation:
https://www.bio.org/events/bio-ceo-investor-digital-conference

its not free for Annovis shareholders..
I want to apologize for anything I get wrong as I am not a detail person and if I had to go back and verify every word of every post I would never post..so please do not base your investment decisions upon anything I post.

disappointed that Annovis chooses a conference to present data where common shareholders have to pay to learn about their Public Company.
I don't believe the Company may release any information not already known as that information would not be accessible to ALL shareholders simultaneously.



If memory serves me correctly:

We are currently awaiting data sets for 68 PD-54 and AD-14 patients in
a completed phase 2a..the data (IMO) will be conclusive that Annovis does indeed safely and therapeutically affect multiple CNS Targets within the CNS Nerve Cell(system) as Annovis and the World hoped.

This Data is estimated to be released in this Quarter by the Company's Own statements.

The reason WHY I believe the data set will come back positive IS the Company has filed a Shelf Registration for $250,000,000 for Capital Raise. They probably will not raise this much money off the news..but IF Stock goes to FAIR Valuation(Over $1 Billion) after good news..
I could see 2.5 million shares offered at $100 per share..
Maybe they will!

What is current FAIR valuation? well there are currently under 7,000,000 share outstanding, so at current price..Market is up today..
A strong Data Set release deserves at least a $500,000,000 valuation:
look at :Personally I think Fair is Over $1 Billion..

Annavex: $800 Million 60 million shares out
Cassava; $1.6 Billion 35 million shares out
AC Immune: $580 million 70 milllion million shares out

Annovis: $150 Million 7 million shares ( approx. Half in Trading Float)

Yu can see that ownership of Annovis Stock is not ONLY at a much Lower Market Cap Price, but shares are much harder to come by..(which in theory should extract a premium to market on good news)..

a $500,000,000 Target Price puts Annovis around $70 Per SHare..
currently the share price is around $25..

Maybe an attendee will be kind enough to post the transcript or Info from Conference on IHUB..consider it officially requested anyone..